September 15, 2023 | Matthew B. Boyd

Related Articles


Explore materials, technologies, design, and manufacturing in the life sciences.



Emerging Applications of Biomaterials in Life Sciences


Biomaterials are an exciting area of biomedical innovation and growth, with emerging applications across the life sciences field. This includes bioactive scaffolds, bioresorbable implants, injectable hydrogels, “organ-on-a-chip” organ models, and self-healing biomaterials. As biomaterials continue to pave the way for transformative innovations, their impact on life sciences and healthcare is becoming increasingly profound. In this article, we will discuss these exciting emerging applications of biomaterials in life sciences. 



Bioactive scaffolds designed for bone repair and regeneration have emerged as one of the fastest-growing applications in the field of biomaterials. These scaffolds are made from materials such as ceramics, polymers, or composites and mimic the structure and composition of natural bone to provide a framework for new bone growth. By incorporating bioactive molecules and growth factors, these scaffolds can stimulate cell proliferation and differentiation, accelerate the healing process, and enhance bone regeneration.

The applications of biomaterial scaffolds for bone repair are wide-ranging. They are used in orthopedic surgeries to treat fractures, non-unions, and critical-sized bone defects. Additionally, they find application in dental implants and maxillofacial reconstruction, where they play a vital role in restoring functionality and aesthetics.

One of the critical advantages of biomaterial scaffolds for bone repair is their ability to guide and stimulate cell proliferation and differentiation. Incorporating bioactive molecules and growth factors within the scaffold provides a favorable microenvironment that promotes the recruitment and attachment of bone-forming cells, such as osteoblasts. These bioactive cues can trigger specific cellular responses, including the production of extracellular matrix and the mineralization of new bone tissue.

Choosing the correct biomaterials for bone scaffolds is crucial to ensure compatibility and effectiveness. Ceramics, such as hydroxyapatite or tricalcium phosphate, are widely used due to their excellent biocompatibility and similarity to the mineral component of natural bone. Polymers, such as polycaprolactone or poly(lactic-co-glycolic acid), offer flexibility in scaffold design and degradation rates. Composites, which combine different materials, can balance mechanical strength and bioactivity.

By mimicking the structure and composition of natural bone tissue and incorporating bioactive molecules, bioactive scaffolds provide a favorable environment for new bone growth and accelerate the healing process. With advancements in materials science and fabrication techniques, these biomaterial scaffolds hold great promise for addressing the increasing prevalence of bone-related disorders and an increase in orthopedic interventions as the population ages.  



Despite widespread use, some problems are associated with traditional implants include the potential for long-term relocation, stress shielding, breakage, adverse material reactions, growth complications with young patients, and interfacing issues with imaging devices. Bioresorbable implants mitigate some of these risks and eliminate the need for surgical removal. This reduces the risk of complications associated with implant removal and eliminates the need for additional procedures, which can save time and resources and minimize patient discomfort. Applications for bioresorbable implants include orthopedics, cardiovascular interventions, and tissue engineering, where they provide temporary support while facilitating tissue regeneration. 

In orthopedics, fracture fixation or bone defect repair procedures utilize bioresorbable materials such as polylactic acid (PLA) and polyglycolic acid (PGA) to create implants that temporarily support the injured bone. Over time, these implants gradually degrade, allowing for the natural healing and regeneration of the bone. As the bone regains its strength, the need for the implant diminishes, and the body eventually absorbs the implant. This eliminates the complications associated with permanent metal implants, such as stress shielding or implant-related infections.

Cardiovascular interventions have also seen notable advancements with the use of bioresorbable implants. In procedures like coronary stenting, where a stent is placed to restore blood flow in a narrowed artery, bioresorbable stents have emerged as an alternative to permanent metal stents. Bioresorbable stents, typically made from materials like polyesters or magnesium alloys, provide temporary scaffolding to support the blood vessel during healing. Over time, the stent degrades and is absorbed by the body, leaving behind a restored and unobstructed blood vessel. This avoids the long-term complications associated with permanent metal stents, such as in-stent restenosis or the need for future interventions.

Tissue engineering is another area where bioresorbable implants have shown promise. In regenerative medicine applications, bioresorbable scaffolds provide temporary structural support while promoting tissue regeneration. These scaffolds can be customized to mimic the properties of the surrounding tissue and facilitate the attachment, growth, and differentiation of cells. Over time, as the tissue regenerates, the scaffold degrades and is gradually replaced by the newly formed tissue. This approach allows for the creation of functional and organized tissues without the need for surgical removal of the implant.

The use of bioresorbable implants represents is a growing application of biomaterials. Their ability to degrade and be absorbed by the body over time eliminates the need for surgical removal, reducing complications and secondary procedures. In orthopedics, cardiovascular interventions, and tissue engineering, bioresorbable implants provide temporary support while facilitating the natural healing and regeneration of tissues. Bioresorbable implants hold great potential for further advancements as well, offering improved patient outcomes, reduced complications, and enhanced treatment options.




Injectable hydrogels offer a three-dimensional environment that supports cell growth, proliferation, and tissue formation. Their potential applications range from cardiac tissue repair and wound healing to cartilage regeneration, with ongoing research exploring their use in various other tissues and organs. As advancements continue in injectable hydrogel formulations and their incorporation of bioactive molecules, these biomaterials hold great promise for tissue engineering and regenerative medicine applications. 

Injectable hydrogels offer several advantages that contribute to their increasing popularity. They can be delivered in liquid form through minimally invasive procedures and undergo gelation in situ, transforming into a gel-like consistency within the tissue defect. This characteristic allows the hydrogel to conform to the shape of the defect, filling irregular spaces and providing structural support.

Injectable hydrogels used for cardiac tissue repair have shown great promise. Following a heart attack, the damaged tissue needs support for regeneration. Injectable hydrogels, often incorporating bioactive molecules or growth factors, can be injected directly into the damaged area, promoting cell survival, angiogenesis (formation of new blood vessels), and cardiac tissue remodeling. These hydrogels provide mechanical support, prevent adverse remodeling, and enhance the formation of functional cardiac tissue.

Chronic wound care applications, such as diabetic ulcers, often face challenges in the healing process. Injectable hydrogels can be applied to the wound bed, creating a moist and supportive environment that promotes cell migration, granulation tissue formation, and re-epithelialization. These hydrogels can also be engineered with growth factors or antimicrobial agents, further enhancing wound healing and reducing the risk of infection.

Injectable hydrogels also have promising applications in cartilage regeneration. Cartilage has limited regenerative capacity, and injuries or degenerative conditions often lead to long-term impairments. Injectable hydrogels can deliver cells, such as chondrocytes or stem cells, to the damaged cartilage site. These hydrogels provide a protective environment for the cells, promoting their survival and differentiation into chondrocyte-like cells. The hydrogel also offers mechanical support and helps maintain the regenerated cartilage's shape and function.

The versatility of injectable hydrogels extends beyond these applications, with ongoing research exploring their use in tissue engineering and regenerative medicine for various other tissues and organs, including bone, liver, and nervous system. Their ability to adapt to irregular defects, provide a suitable environment for cell growth, and deliver bioactive molecules makes them a promising biomaterial platform.



Organs-on-a-chip are microscale systems that mimic the structure and function of human organs, enabling the study of organ-level responses to drugs, diseases, and external stimuli. Biomaterials are critical in creating these microenvironments by providing suitable scaffolds and surfaces for cell growth and integrating vascular networks to mimic the natural blood supply. These biomaterial-based organ models have the potential to revolutionize drug screening, personalized medicine, and our understanding of organ physiology.

The use of organs-on-a-chip has significant implications for drug screening and development, where these platforms can provide more accurate and predictive models for assessing the efficacy and toxicity of pharmaceutical compounds. By studying how drugs interact with specific organ models on a chip, researchers can better understand their effects, optimize dosages, and identify potential side effects or adverse reactions.

Organ-on-a-chip systems also hold great promise for personalized medicine. These platforms can be derived from patient-specific cells, allowing for the creation of organ models that closely resemble an individual's physiology. This customized approach can facilitate tailored drug testing, disease modeling, and the development of precision therapeutic strategies.

Additionally, organ-on-a-chip systems are valuable for studying organ physiology and disease mechanisms. By replicating the structure and function of organs, researchers can investigate the complex interactions between different cell types, evaluate disease progression, and explore the underlying mechanisms of various pathologies. This knowledge can lead to new insights into disease processes, identifying novel therapeutic targets, and more effective overall therapeutic strategies. 

Organ-on-a-chip systems have the potential to revolutionize drug screening, personalized medicine, and our understanding of organ physiology. With these models, we can improve drug testing accuracy, enable tailored therapies, and offer insights into complex disease mechanisms.


Upma Sharma on the next evolution of biomedical devices from metal to plastic to biomaterials. 



Biomaterials are being used to develop and improve neural interfaces that establish communication between neural tissues and external devices. These interfaces, such as neural electrodes or neural probes, are designed to record or stimulate neural activity. Neural interfaces play a crucial role in several fields, including neural prosthetics, brain-computer interfaces, and deep brain stimulation. These devices have great potential to create medical treatments which enhance the quality of life for individuals with neurological disorders or injuries. 

Biomaterials are increasingly incorporated into the design of neural interfaces to improve their biocompatibility, functionality, and long-term performance. Biomaterial coatings serve to enhance the biocompatibility of these devices with neural tissues reducing the immune response and promoting the integration of the interface with the surrounding neural environment. By minimizing the foreign body response and the formation of scar tissue, these coatings can improve the long-term stability and functionality of neural interfaces.

Biomaterial coatings can be tailored to provide specific properties that are beneficial for neural interfaces. For example, the surface of the biomaterial can be modified to promote cell adhesion and facilitate the growth of neurons, ensuring a closer and more efficient interaction with the neural tissue. Additionally, these coatings can be designed to have controlled release properties, allowing for the localized delivery of therapeutic agents or neurotrophic factors to promote tissue regeneration or neuroprotection.

In the field of neural prosthetics, biomaterial-based neural interfaces have shown promise in restoring motor function to individuals with limb loss or paralysis. Neural electrodes implanted in the brain or peripheral nerves can record neural signals related to movement intention, which are then translated into commands to control prosthetic limbs or assistive devices. The use of biomaterial coatings on these electrodes can improve their biocompatibility and long-term stability, reducing the risk of tissue damage and enhancing the accuracy and reliability of signal recording.

Brain-computer interfaces (BCIs) represent another exciting application of biomaterial-based neural interfaces. BCIs allow individuals to control external devices, such as computers or robotic systems, directly through their neural activity. Biomaterial coatings on the electrodes used in BCIs can improve their biocompatibility and reduce the risk of tissue inflammation or rejection, enabling long-term and reliable communication between the brain and the external device.
Deep brain stimulation (DBS) is a therapeutic technique that involves the implantation of electrodes in specific regions of the brain to modulate neural activity and treat neurological disorders such as Parkinson's disease or essential tremor. Biomaterial coatings on DBS electrodes can enhance their biocompatibility, reducing the immune response and improving the efficacy and longevity of the stimulation.

Neural interfaces represent one of the fastest-growing applications of biomaterials with tremendous opportunity to address unmet patient needs. By incorporating biomaterials into the design of these interfaces, researchers and engineers are improving their biocompatibility, stability, and functionality. This opens up new possibilities for neural prosthetics, brain-computer interfaces, and deep brain stimulation, leading to advancements in medical treatments, neurorehabilitation, and our understanding of the human brain.



The development of self-healing biomaterials is an exciting area of biomedical innovation. These biomaterials possess the remarkable ability to repair themselves when damaged or degraded, mimicking the regenerative properties observed in living tissues. Self-healing biomaterials have applications in areas such as implantable devices, tissue engineering, and wound healing, where the ability to repair and regenerate damaged structures is crucial.

Self-healing biomaterials function by autonomously detecting and responding to mechanical or chemical stimuli and then initiating a healing process. When a material is subjected to damage, such as a crack or rupture, the healing process is triggered. The healing process can occur through various mechanisms, including the release of encapsulated healing agents, the activation of embedded microvascular networks, and the reformation of chemical bonds within the material.

One approach involves the incorporation of healing agents, such as polymer chains or nanoparticles, within the material matrix. These agents remain dormant until the material is damaged, at which point they are released and flow into the damaged region. Through chemical reactions or physical interactions, the healing agents can bond together, effectively sealing a crack and restoring the material's integrity.

Another strategy involves the integration of microvascular networks within the biomaterial. These vascular networks mimic the circulatory system found in living tissues and can be designed to release healing agents or carry regenerative cells to the damaged site. When damage occurs, the network can respond by delivering the necessary components for repair, such as growth factors, cells, or nutrients. This approach enables the biomaterial to repair itself by facilitating tissue regeneration and restoration of its original properties.

Advances in self-healthing biomaterials enabling exciting advancements in several clinical applications. In the context of orthopedic implants, such as bone plates or screws, self-healing materials can help address common issues such as stress shielding and loosening. When subjected to mechanical stresses, these materials can detect and heal microcracks, preventing further damage and maintaining the stability and functionality of the implant over time.

In tissue engineering, self-healing biomaterials offer the potential to enhance the success of engineered constructs. By incorporating self-healing properties into scaffolds or matrices, these materials can repair defects that may occur during fabrication or transplantation. This self-repair capability ensures the structural integrity of the tissue-engineered construct and promotes better integration with the surrounding native tissue, leading to improved outcomes in tissue regeneration and organ transplantation.

Additionally, self-healing biomaterials hold promise in wound healing applications. Chronic or non-healing wounds present significant challenges in clinical practice. By using self-healing biomaterials as dressings or scaffolds, it is possible to create an environment that actively promotes wound healing. When the material detects damage within the wound, it can initiate the healing process by delivering therapeutic agents, promoting cell migration, and facilitating tissue regeneration, ultimately leading to faster and more effective wound closure.

The development of self-healing biomaterials offers the potential to enhance the performance and longevity of these clinical applications. By enabling materials to repair and regenerate themselves, self-healing biomaterials can contribute to improved patient outcomes, reduced complications, and increased overall functionality of implanted devices, tissue-engineered constructs, and wound healing therapies.



These applications of biomaterials represent some of the most exciting areas of growth and innovation in healthcare. As researchers continue to push the boundaries of biomaterials, which we explore in depth, their contribution to life sciences holds the promise of transformative innovation which can address unmet patient needs, provide more personalized care, and improve healthcare for patients around the world.


Explore materials, technologies, design, and manufacturing in the life sciences.


Articles & Resources

Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together we're advancing biomedical innovation through curiosity and shared knowledge. 


Video Series

Boyd Biomedical Design Stories explores what it takes to commercialize biomedical innovations in a modern susteainable way. A way that's the best way - for patients, practitioners, and all of us - as we seek to advance healthcare together. 


Documentary Film

Project Frontline is a feature length documentary film which tells the inspiring story of collaboration during crisis and is a cautionary tale about our leadership in innovation, advanced manufacturing, and supply chain resilience.